Skip to main content

KPV vs Pinealon

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

KPV

KPV is a tripeptide (Lys-Pro-Val) derived from alpha-melanocyte-stimulating hormone (α-MSH). It retains the potent anti-inflammatory properties of the parent hormone without the tanning or other melanocortin effects.

Full details →

Pinealon

Pinealon is a short synthetic peptide developed from research on the pineal gland. It has shown neuroprotective and cognitive-enhancing properties in animal studies.

Full details →

Side-by-Side Comparison

AspectKPVPinealon
MechanismInhibits NF-κB activation and reduces inflammatory cytokine production. Enters cells and directly modulates inflammatory signaling without requiring melanocortin receptors.Penetrates cell membranes and interacts with DNA to regulate gene expression related to neuronal survival and function. May support pineal gland function and melatonin production.
Typical DosageOral/sublingual: 200-500mcg 1-3 times daily. Topical formulations for localized inflammation. Also used in enemas for gut inflammation.Typical dosing: 10-20mg daily, taken in divided doses. Often used in cycles of 10-20 days.
AdministrationCan be taken orally, sublingually, or as suppositories/enemas for gut inflammation. Topical use for skin conditions. Stable orally unlike most peptides.Can be taken orally (capsules) or sublingually. Best absorbed on an empty stomach. Often combined with other neuroprotective peptides.
Side EffectsGenerally very well-tolerated. Minimal systemic effects due to targeted anti-inflammatory action.Generally well-tolerated. Limited reported side effects. May affect sleep patterns initially.
Best For

Key Differences

Detailed Analysis

KPV and Pinealon are used for different purposes and have limited overlap in their applications.

Which Should You Choose?

Choose KPV for Recovery & Healing, Gut Health, Skin Health & Aesthetics. Choose Pinealon for Sleep Quality, Cognitive Performance.

Ready to Learn More?